Physician profile
Thierry Momplaisir
NPI 1255420899
$65,390.43
in general payments reported to CMS, 2019-2025
34 companies · $3,365 in 2025
The $3,365 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $14K · 2021: $14K · 2022: $10K · 2023: $7,866 · 2024: $5,454 · 2025: $3,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $3,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,456.01 |
| Travel and Lodging | $3,228.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $21,807.03 | 2019-2023 | Brilinta |
| Boston Scientific Corporation | $6,330.86 | 2019-2025 | Watchman Access System, General - Balloon Catheters, Watchman Flx |
| Abbott Laboratories | $5,699.44 | 2019-2025 | Mitraclip, Amplatzer Amulet, Amplatzer Talisman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,219.60 | 2019-2023 | Lifevest |
| Medtronic, INC. | $4,732.54 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abiomed | $4,293.71 | 2019-2025 | Impella |
| Penumbra, INC. | $3,944.88 | 2019-2024 | Indigo System |
| Medtronic Vascular, INC. | $3,348.13 | 2019-2020 | |
| Edwards Lifesciences Corporation | $2,672.05 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Cardiva Medical, INC. | $1,335.87 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $1,303.14 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $589.64 | 2023-2025 | Nuvision Ice Catheter, Na |
| Inari Medical, INC. | $469.11 | 2020-2021 | |
| Livanova USA, INC. | $467.81 | 2019-2023 | Lifesparc |
| Medical Device Business Services, INC. | $422.80 | 2023 | Carto 3 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $304.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $284.47 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $260.49 | 2021-2024 | Camzyos |
| Getinge USA Sales, LLC | $247.70 | 2019-2021 | |
| Cardiovascular Systems INC. | $216.94 | 2019-2020 | |
| Cvrx, INC. | $213.08 | 2022-2025 | Barostim Neo System |
| Amgen INC. | $200.92 | 2020 | |
| Pfizer INC. | $200.20 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $180.39 | 2023-2025 | Optimizer, Optimizer |
| W. L. Gore & Associates, INC. | $149.33 | 2021 | |
| Siemens Medical Solutions USA, INC. | $120.11 | 2020 | |
| Novartis Pharmaceuticals Corporation | $106.61 | 2019-2021 | |
| American Regent | $93.93 | 2024 | Injectafer |
| Teleflex LLC | $73.42 | 2023-2024 | Manta |
| Cardinal Health 200 LLC | $33.20 | 2019 | |
| Preventice Services, LLC | $23.06 | 2021 | |
| Cordis US Corp. | $17.77 | 2023 | Radial 360 |
| Sanofi-Aventis U.S. LLC | $14.46 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.06 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thierry Momplaisir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.